CK19 protein expression was detected in 20/51 cases of benign lesions (44.7% HNs, and 0% FA), focally in 3/12 (25%) in NIFTP, and in 14/20 in carcinomas (64.7% FVPTC and 100% FC). Here, KRT19 is linked to carcinoma.